Mason Investment Advisory Services, Inc. Gilead Sciences, Inc. Transaction History

Mason Investment Advisory Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Aug 02, 2024	SELL	$61.62 - $67.78 $2,649 - $2,914	-43 Reduced 0.22%	19,676 $1.28 Billion
Q3 2019 Aug 02, 2024	BUY	$62.51 - $69.0 $174,402 - $192,510	2,790 Added 16.48%	19,719 $1.25 Billion
Q2 2019 Aug 02, 2024	BUY	$61.87 - $69.38 $89,958 - $100,878	1,454 Added 9.4%	16,929 $1.14 Billion
Q1 2019 Aug 02, 2024	BUY	$62.53 - $70.05 $967,651 - $1.08 Million	15,475 New	15,475 $1.01 Billion

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mason Investment Advisory Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Mason Investment Advisory Services, Inc. with notifications on news.